9 results about "Bowel cleansing" patented technology

The present invention can provide: a colon purgation tablet having a gel-forming coating layer containing an alginate as a main component, the gel-forming coating layer being introduced into an uncoated tablet containing an osmotic substance, the present invention relates to an uncoated tablet, and more particularly, to an uncoated tablet, such that the osmotic substance contained in the uncoated tablet disintegrates rapidly while preventing damage to gastric mucosa due to a physical collision between the tablet and the gastric mucosa, and thus provides an excellent intestinal cleansing effect. The colon purgation tablet according to the present invention can exhibit an excellent intestinal cleansing effect even at a small dose, and can further improve drug compliance by selectively miniaturizing the tablet or introducing an adhesive to improve a coating layer.

Disclosed herein are methods of administering compositions comprising a mixture of salts that induce purgation of the colon and are useful to cleanse the colon. Furthermore, the disclosed methods prevent degradation of PEG and allow for cleansing of the colon without the use of adjunct laxatives, including stimulant laxatives such as bisacodyl. The disclosed methods are superior to the prior art in that they allow for higher tolerability, improved safety, lower volumes, and improved patient compliance.

The present invention relates to a colon cleansing composition with improved ease of administration. The composition minimizes side effects caused by excessive ingredient content in conventional colonic laxatives while providing equivalent or superior intestinal cleansing efficacy, thereby remarkably improving patient compliance and ingestion convenience. In addition, as an uncoated tablet requiring no separate coating processes, a preparation that maintains the quality of tablets such as rapid disintegration and does not have a bitter taste can be provided. The present invention provides a pharmaceutical formulation comprising the colon cleansing composition with improved ease of administration and a method for colon cleansing using the formulation, thereby realizing a patient-centered colon cleansing process and ultimately greatly contributing to the improvement of colonoscopy quality.

Disclosed herein are methods of administering compositions comprising a mixture of salts that induce purgation of the colon and are useful to cleanse the colon. Furthermore, the disclosed methods prevent degradation of PEG and allow for cleansing of the colon without the use of adjunct laxatives, including stimulant laxatives such as bisacodyl. The disclosed methods are superior to the prior art in that they allow for higher tolerability, improved safety, lower volumes, and improved patient compliance.

The utility model relates to a gut-purging medicament mixing and dissolving device with a separating function, belongs to the technical field of medical instruments, and solves the technical problem that the drinking amount of gut-purging medicaments taken in different times can be controlled only by using a measuring tool in the prior art. The garbage can comprises a can body and a separator, the barrel body is provided with a cavity for accommodating a bowel cleaning medicament; the separator is arranged in the barrel body; the partition piece comprises a plurality of partition plates, and the partition plates divide the cavity into a plurality of sub-cavities. According to the utility model, the cavity in the barrel body is divided into a plurality of sub-cavities by the partition plates, so that the technical effect of accurately controlling the dosage of the gut purging medicament can be realized without a measuring tool when a patient takes the gut purging medicament in the sub-cavities every time.

This utility model discloses an intelligent bowel-cleansing toilet seat, belonging to the field of intelligent bathroom technology. It includes a toilet seat, a compartment, a bowel-cleansing system, a spray system, an intelligent control system, and a drying and sterilization system. The bowel-cleansing system uses a moving nozzle to precisely position a flexible tube in the center of the toilet seat, allowing the user to directly insert the tube into the anus. Overflowing water is injected into the intestines to soften hardened stool and guide it to be expelled naturally. After bowel cleansing, the spray system rinses the flexible tube with alternating high-frequency, high-flow and low-frequency, low-flow water. The drying and sterilization system disinfects with hot air and ultraviolet light. The entire process is automatically completed by the intelligent control system, achieving a simple, convenient, hygienic, and safe bowel-cleansing operation, solving the pain points of traditional enemas being complex, cumbersome, inconvenient, and posing high hygiene risks.

The present invention relates to a composition for bowel cleansing, comprising polyethylene glycol, sulfate and ascorbate ingredients.

The present disclosure provides systems, kits, and methods for preparation prior to colonoscopy or other colon-related gastrointestinal procedures. In particular, the present invention provides a drug delivery system for gut cleansing products and procedures. The drug delivery system includes a capsule or tablet assembly that can be loaded with salts and other related drugs for use in gut cleansing products and still floats in the stomach after ingestion due to a density of 1.004 gm / ml or less. The drug delivery system avoids mass aggregation of salt near the gastric mucosa during the disintegration phase, thereby reducing the risk of direct gastric mucosal damage that may occur by solid enteral cleansing products.

The present disclosure relates to compositions and methods for treating autism spectrum disorder (ASD) by restoring an ASD patient's gut microbiota. These methods can be used with ASD patient with or without ongoing gastrointestinal symptoms. Provided here is a method for ASD treatment in a subject in need thereof comprising or consisting essentially of administering a therapeutic composition comprising a fecal microbe or a fecal microbiota preparation to the subject. Also provided here is a method comprises administering an antibiotic to a human subject; subjecting the human subject to a bowel cleanse; and administering purified fecal microbiota to the human subject. Further provided are evaluation and quantitative characterization of patient symptom improvements upon treatment described here.